| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 16,4 k € | -90.7% | 177,1 k € | -11.8% | 200,7 k € | -14.8% | 235,6 k € | +62.0% | 145,4 k € | +74.8% | 83,2 k € | +130.2% | 36,1 k € | +74.1% | 20,8 k € | -42.6% | 36,2 k € | -3.2% | 37,4 k € | -53.7% | 80,7 k € | +9.4% | 73,8 k € | +2.7% | 71,8 k € | +4.5% | 68,8 k € | -7.2% | 74,1 k € | +29.3% | 57,3 k € | |
| EBITDA | 9,9 k € | +423.6% | -3,1 k € | -106.4% | 47,4 k € | -51.3% | 97,3 k € | +119.2% | 44,4 k € | +234.8% | 13,3 k € | +165.9% | -20,1 k € | -1025.4% | -1,8 k € | -105.4% | 33,3 k € | -9.9% | 37,0 k € | -53.7% | 79,9 k € | +9.7% | 72,8 k € | +3.3% | 70,5 k € | +3.4% | 68,2 k € | -6.7% | 73,1 k € | +29.4% | 56,4 k € | |
| Operating profit | -29,8 k € | -309.4% | -7,3 k € | -117.1% | 42,5 k € | -54.3% | 93,0 k € | +124.0% | 41,5 k € | +263.3% | 11,4 k € | +149.4% | -23,1 k € | -372.0% | -4,9 k € | -133.7% | 14,6 k € | -30.0% | 20,8 k € | -67.6% | 64,2 k € | +15.7% | 55,5 k € | +4.4% | 53,1 k € | +55.7% | 34,1 k € | -14.5% | 39,9 k € | +75.6% | 22,7 k € | |
| Profit/loss | -31,1 k € | -183.2% | -11,0 k € | -210.0% | 10,0 k € | -85.0% | 66,8 k € | +104.4% | 32,7 k € | +168.7% | 12,2 k € | +155.3% | -22,0 k € | -568.1% | -3,3 k € | -120.6% | 16,0 k € | +4.0% | 15,4 k € | -60.9% | 39,4 k € | +5.1% | 37,4 k € | +6.7% | 35,1 k € | +63.1% | 21,5 k € | -9.1% | 23,7 k € | +126.6% | 10,4 k € | |
| Equity | 191,7 k € | -14.0% | 222,9 k € | -4.7% | 233,9 k € | +4.5% | 223,9 k € | +42.6% | 157,0 k € | +26.3% | 124,3 k € | +10.8% | 112,2 k € | -16.4% | 134,2 k € | -12.0% | 152,5 k € | +0.7% | 151,5 k € | -18.6% | 186,1 k € | +26.8% | 146,7 k € | +34.3% | 109,3 k € | +47.3% | 74,2 k € | +40.8% | 52,7 k € | +81.5% | 29,0 k € | |
| Total assets | 205,9 k € | -33.4% | 309,3 k € | -31.9% | 454,2 k € | -26.3% | 616,6 k € | +127.9% | 270,5 k € | +55.0% | 174,6 k € | +2.2% | 170,8 k € | +1.1% | 169,0 k € | -12.8% | 193,7 k € | +5.1% | 184,3 k € | -14.9% | 216,6 k € | +10.9% | 195,3 k € | -1.1% | 197,4 k € | -15.0% | 232,3 k € | -8.5% | 253,9 k € | -2.9% | 261,4 k € | |
| Cash | 52,9 k € | +131.0% | 22,9 k € | -77.0% | 99,5 k € | -24.1% | 131,0 k € | +60.4% | 81,7 k € | +58.5% | 51,5 k € | +19.0% | 43,3 k € | +84.2% | 23,5 k € | -43.4% | 41,5 k € | -39.8% | 69,0 k € | -17.8% | 83,8 k € | +32.0% | 63,5 k € | +18.0% | 53,9 k € | -16.0% | 64,1 k € | +46.5% | 43,8 k € | +34.7% | 32,5 k € | |
| Debts | 14,1 k € | -83.7% | 86,4 k € | -60.8% | 220,4 k € | -43.9% | 392,8 k € | +246.0% | 113,5 k € | +125.9% | 50,2 k € | -14.3% | 58,6 k € | +68.5% | 34,8 k € | -15.6% | 41,2 k € | +25.7% | 32,8 k € | +7.4% | 30,5 k € | -37.1% | 48,6 k € | -43.1% | 85,3 k € | -45.1% | 155,3 k € | -22.7% | 200,9 k € | -13.4% | 231,9 k € | |
| Staff | — | 2,7 | 2,7 | 1,7 | 1,7 | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||
Private company with limited liability · Ciney · incorporated on 09/02/2010
Private company with limited liability loss-making in the latest fiscal year. Cash position rising (+131.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Pharmacie Pirot-Grosjean is a Private company with limited liability incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ciney.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette